Evidence map›Paper›PMID 28060894›Full record

ArticlePloS one2017

The Effect of Cadence on Shank Muscle Oxygen Consumption and Deoxygenation in Relation to Joint Specific Power and Cycling Kinematics.

Knut Skovereng, Gertjan Ettema, Mireille van Beekvelt

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Knut SkoverengCentre for Elite Sports Research, Department of Neuroscience, Norwegian University of Science and Technology, Trondheim, NORWAY.ORCID http://orcid.org/0000-0002-4392-9704
Gertjan EttemaCentre for Elite Sports Research, Department of Neuroscience, Norwegian University of Science and Technology, Trondheim, NORWAY.
Mireille van BeekveltCentre for Elite Sports Research, Department of Neuroscience, Norwegian University of Science and Technology, Trondheim, NORWAY.
Norwegian University of Science and Technology · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The purpose of the present study was to investigate the effect of cadence on joint specific power and cycling kinematics in the ankle joint in addition to muscle oxygenation and muscle VO2 in the gastrocnemius and tibialis anterior. Thirteen cyclists cycled at a cadence of 60, 70, 80, 90, 100 and 110 rpm at a constant external work rate of 160.1 ± 21.3 W. Increasing cadence led to a decrease in ankle power in the dorsal flexion phase and to an increase in ankle joint angular velocity above 80 rpm. In addition, increasing cadence increased deoxygenation and desaturation for both the gastrocnemius and tibialis anterior muscles. Muscle VO2 increased following increased cadence but only in the tibialis anterior and only at cadences above 80 rpm, thus coinciding with the increase in ankle joint angular velocity. There was no effect of cadence in the gastrocnemius. This study demonstrates that high cadences lead to increased mVO2 in the TA muscles that cannot be explained by power in the dorsal flexion phase.

Indexed as

BicyclingOxidation-ReductionOxygen ConsumptionAdultBiomarkersBiomechanical PhenomenaHeart RateHumansJointsMiddle AgedMuscle, SkeletalMuscle StrengthRespiratory Function TestsBiomarkers

Identifiers

PMID28060894
PMCPMC5217861
OpenAlexW2569444283

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.